Loading…

Nippon Shokubai signed a contract to acquire all shares of U.S. chemical technology venture SIRRUS Inc., making it a subsidiary. The deal is expected to close in March 2017. SIRRUS holds technology for diethyl methylene malonate (DEMM) and derivatives.
“当社では2014年度にスタートした長期経営計画「新生日本触媒 2020」において、アクリル酸・SAP事業に続く大型の新規事業創出に取り組んでいます。”nikkei.com
Summarized from public sources; check the original articles before acting on it.